Pyrosequencing for rapid detection of tuberculosis resistance to Rifampicin and Isoniazid in Syrian and Lebanese clinical isolates

International Journal of Mycobacteriology

Volumn 4, Issue 3, 2015, Pages 228-232

  Hamze, M ^a   Ismail, M B ^a   Rahmo, A K ^b   Dabboussi, F ^a  

^a LEBANESE UNIVERSITY   (Lebanon)

^b National Commission for Biotechnology   (Syrian Arab Republic)

Author keywords

Isoniazid; Lebanon; M. tuberculosis; Pyrosequencing; Rifampicin; Syria

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

AHPC OXYR GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CODON; DNA SEQUENCE; GENE MUTATION; HUMAN; INHA GENE; KATG GENE; LEBANESE; MISSENSE MUTATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; RPOB GENE; SEQUENCE ANALYSIS; SYRIAN; TUBERCULOSIS; DNA MUTATIONAL ANALYSIS; DRUG EFFECTS; EVALUATION STUDY; GENETICS; LEBANON; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PUBLIC HEALTH; REFUGEE; SENSITIVITY AND SPECIFICITY; SYRIAN ARAB REPUBLIC;

MYCOBACTERIUM TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CODON; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HUMANS; ISONIAZID; LEBANON; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; MYCOBACTERIUM TUBERCULOSIS; PUBLIC HEALTH; REFUGEES; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SYRIA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84938741402     PISSN: 22125531     EISSN: 2212554X     Source Type: Journal    
DOI: 10.1016/j.ijmyco.2015.05.007     Document Type: Article

References (21)

1. Tuberculosis, Current Health Event, Epi-Monitor. Published Jointly by the Lebanese Ministry of Public Health (MOPH) and the World Health Organization (WHO). Issue 14, 2014.
2. Dalton T., Cegielski P., Akksilp S., Asencios L., Caoili J.C., Cho S.N., et al. Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet 2012, 380:1406-1417.
3. Ajbani K., Lin S.Y., Rodrigues C., Nguyen D., Arroyo F., Kaping J. Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries. Antimicrob. Agents Chemother. 2015, 59:414-420.
4. Ho Y.M., Sun Y.J., Wong S.Y., Lee A.S. Contribution of dfrA and inhA mutations to the detection of isoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 2009, 53:4010-4012.
5. Rahmoa A., Hamdarb Z., Kasaab I., Dabboussib F., Hamze M. Genotypic detection of rifampicin-resistant M. tuberculosis strains in Syrian and Lebanese patients. J. Infect. Public Health 2012, 5:381-387.
6. Yao C., Zhu T., Li Y., Zhang L., Zhang B., Huang J., et al. Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray. Clin. Microbiol. Infect. 2010, 16:1639-1643.
7. Hamze M., Rahmo A., Saade M. Characterization of Mycobacterium tuberculosis of Lebanese patients by double-repetitive-element polymerase chain reaction. East. Mediterr. Health J. 2010, 16:812-819.
8. Rahmo A., Hamze M. Characterization of Mycobacterium tuberculosis in Syrian patients by double-repetitive-element polymerase chain reaction. East. Mediterr. Health J. 2010, 16:820-830.
9. Zhao J.R., Bai Y.J., Wang Y., Zhang Q.H., Luo M., Yan X.J. Development of a pyrosequencing approach for rapid screening of rifampin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 2005, 9:328-332.
10. Bravo L.T.C., Tuohy M.J., Ang C., Destura R.V., Mendoza M., Procop G.W., et al. Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones. J. Clin. Microbiol. 2009, 47:3985-3990.
11. Mokrousov I., Narvskaya O., Otten T., Limeschenko E., Steklova L., Vyshnevskiy B. High Prevalence of katG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from Northwestern Russia 1996 to 2001. Antimicrob. Agents Chemother. 2002, 46:1417-1424.
12. Marttila H.J., Mäkinen J., Marjamäki M., Soini H. Prospective evaluation of pyrosequencing for the rapid detection of isoniazid and rifampin resistance in clinical Mycobacterium tuberculosis isolates. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28:33-38.
13. Haas W.H., Schilke K., Brand J., Amthor B., Weyer K., Fourie R.B., et al. Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa. Antimicrob. Agents Chemother. 1997, 41:1601-1603.
14. Zhang M., Yue J., Yang Y.P., Zhang H.M., Lei J.Q., Jin R.L., et al. Detection of mutation associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J. Clin. Microbiol. 2005, 43:5477-5482.
15. Fenner L., Egger M., Bodmer T., Altpeter E., Zwahlen M., Jaton K., et al. Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2012, 56:3047-3053.
16. Rindi L., Bianchi L., Tortoli E., Lari N., Bonanni D., Garzelli C. Mutations responsible for Mycobacterium tuberculosis isoniazid resistance in Italy. Int. J. Tuberc. Lung Dis. 2005, 9:94-97.
17. Huang W.L., Chen H.Y., Kuo Y.M., Jou R. Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 2011, 47:2520-2524.
18. Grace Lin S.Y., Rodwell T.C., Victor T.C., Rider E.C., Pham L., et al. Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens. J. Clin. Microbiol. 2014, 52:475-482.
19. Zhang Y. The magic bullets and tuberculosis drug targets. Annu. Rev. Pharmacol. Toxicol. 2005, 45:529-564.
20. Mani C., Selvakumar N., Narayanan S., Narayanan P.R. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. J. Clin. Microbiol. 2001, 39:2987-2990.
21. Sekiguchi J., Miyoshi-Akiyama T., Augustynowicz-Kope E., Zwolska Z., Kirikae F., Toyota E., et al. Detection of multidrug resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 2007, 1:179-192.